D-1541-2022 Class III Terminated

Recalled by UNICHEM PHARMACEUTICALS USA INC — East Brunswick, NJ

FDA drug recall D-1541-2022 was initiated by UNICHEM PHARMACEUTICALS USA INC on Sep 19, 2022 and is designated Class III. Reason for recall: Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets, The recall status is terminated (terminated Mar 2, 2023). Affected quantity: 18,960 bottles of 100.

Recall details

Product Type
Drugs
Report Date
Sep 28, 2022
Initiation Date
Sep 19, 2022
Termination Date
Mar 2, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18,960 bottles of 100

Product description

Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC. East Brunswick, NJ 08816. NDC# 29300-137-01

Reason for recall

Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot # GCLH22005, exp. date 02/29/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1541-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1541-2022. Report a data issue: hello@regdatalab.com.